1-2 of 2
Nobuharu Fujii
Close
Sort by
Journal Articles

Distribution and clinical impact of molecular subtypes with dark zone signature of DLBCL in a Japanese real-world study

Tomohiro Urata, Yusuke Naoi, Aixiang Jiang, Merrill Boyle, Kazutaka Sunami, Toshi Imai, Yuichiro Nawa, Yasushi Hiramatsu, Kazuhiko Yamamoto, Soichiro Fujii, Isao Yoshida, Tomofumi Yano, Ryota Chijimatsu, Hiroyuki Murakami, Kazuhiro Ikeuchi, Hiroki Kobayashi, Katsuma Tani, Hideki Ujiie, Hirofumi Inoue, Shuta Tomida, Akira Yamamoto, Takumi Kondo, Hideaki Fujiwara, Noboru Asada, Hisakazu Nishimori, Keiko Fujii, Nobuharu Fujii, Ken-ichi Matsuoka, Keisuke Sawada, Shuji Momose, Jun-ichi Tamaru, Asami Nishikori, Yasuharu Sato, Tadashi Yoshino, Yoshinobu Maeda, David W. Scott, Daisuke Ennishi
Journal: Blood Advances
Blood Adv (2023) 7 (24): 7459–7470.
https://doi.org/10.1182/bloodadvances.2023010402
Published: 2023
Includes: Supplemental data
Journal Articles

Early initiation of low-dose gilteritinib maintenance improves posttransplant outcomes in patients with R/R FLT3 mut AML

Clinical Trials & Observations
Toshiki Terao, Ken-ichi Matsuoka, Hiroko Ueda, Akifumi Matsumura, Chisato Matsubara, Kaho Kondo, Takumi Kondo, Hideaki Fujiwara, Noboru Asada, Daisuke Ennishi, Hisakazu Nishimori, Keiko Fujii, Nobuharu Fujii, Yoshinobu Maeda
Journal: Blood Advances
Blood Adv (2023) 7 (5): 681–686.
https://doi.org/10.1182/bloodadvances.2022008991
Published: 2023
Includes: Supplemental data